Launch approval for MEDEVAC aircraft requires appropriate Aviation Command level approval based on risk level, which includes levels such as Low-Company and Ex-High-First GO.

• A. Low-Company, Moderate-BN, High-CAB, Ex-High-First GO
• B. Only the Medical Officer
• C. The unit commander
• D. Random time-based approvals

Answer: (A)

Risk-based approval authority governs MEDEVAC launches, with the level of aviation command authorization rising as the assessed risk increases. The best choice reflects that escalation: low-risk missions can be approved at the company level, moderate risk at the battalion level, high risk at the Combat Aviation Brigade, and the most extreme risk at the Ex-High-First GO level. This structure keeps decisions timely while ensuring appropriate oversight at each tier, matching safety and accountability to the mission’s risk.

The other options don’t fit because approvals aren’t centralized to a single medical officer, nor should they be handled solely by the unit commander without the corresponding aviation command involvement. Random, time-based approvals ignore risk and policy requirements.